|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Baricitinib, (Obo) Atc L04Aa37 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Peg-Epoetin Beta, (Obo) Atc B03Xa03 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Flupentixol, (Obg) Atc N05Af01 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Baricitinib, (Obo) Atc L04Aa37 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Mepolizumab, (Obo) Atc R03Dx09 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Lipegfilgrastim, (Obo) Atc L03Aa14 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Peg-Epoetin Beta, (Obo) Atc B03Xa03 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
Health Insurance Services Tenders and Contracts
Health Insurance Services tenders contracts bids and business opportunities -
Healthcare and Medicine